111 (NASDAQ:YI) Trading 0.3% Higher

111, Inc. (NASDAQ:YIGet Rating) traded up 0.3% on Wednesday . The company traded as high as $3.02 and last traded at $2.99. 40,027 shares changed hands during trading, a decline of 73% from the average session volume of 149,240 shares. The stock had previously closed at $2.98.

111 Stock Performance

The business has a 50 day moving average of $3.12 and a two-hundred day moving average of $2.90.

111 (NASDAQ:YIGet Rating) last issued its quarterly earnings data on Thursday, December 1st. The company reported ($0.16) earnings per share for the quarter. The company had revenue of $470.76 million during the quarter.

Institutional Investors Weigh In On 111

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in YI. Prelude Capital Management LLC purchased a new stake in 111 in the third quarter valued at about $291,000. Renaissance Technologies LLC raised its stake in 111 by 231.0% in the second quarter. Renaissance Technologies LLC now owns 109,047 shares of the company’s stock valued at $225,000 after buying an additional 76,100 shares during the last quarter. Virtu Financial LLC purchased a new stake in 111 in the second quarter valued at about $118,000. Citadel Advisors LLC purchased a new stake in 111 in the second quarter valued at about $107,000. Finally, Maven Securities LTD purchased a new stake in 111 in the third quarter valued at about $75,000. 47.54% of the stock is currently owned by hedge funds and other institutional investors.

111 Company Profile

(Get Rating)

111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.

Featured Articles

Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.